Chemours (CC)
(Delayed Data from NYSE)
$24.32 USD
+0.43 (1.80%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $24.33 +0.01 (0.04%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for The Chemours Company falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,807 | 1,102 | 1,451 | 1,105 | 943 |
Receivables | 610 | 626 | 720 | 511 | 674 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,352 | 1,404 | 1,099 | 939 | 1,079 |
Other Current Assets | 66 | 82 | 75 | 78 | 81 |
Total Current Assets | 3,835 | 3,214 | 3,345 | 2,633 | 2,777 |
Net Property & Equipment | 3,216 | 3,171 | 3,154 | 3,474 | 3,559 |
Investments & Advances | 158 | 175 | 169 | 167 | 162 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 105 | 115 | 108 | 167 | 174 |
Deposits & Other Assets | 677 | 725 | 547 | 405 | 292 |
Total Assets | 8,251 | 7,640 | 7,550 | 7,082 | 7,258 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1,159 | 1,251 | 1,162 | 844 | 923 |
Current Portion Long-Term Debt | 51 | 25 | 25 | 21 | 134 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1,058 | 300 | 325 | 577 | 484 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 218 | 315 | 346 | 0 | 0 |
Total Current Liabilities | 2,486 | 1,891 | 1,858 | 1,442 | 1,541 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 44 | 61 | 49 | 36 | 118 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 3,987 | 3,590 | 3,724 | 4,005 | 4,026 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 789 | 793 | 658 | 590 | 633 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 7,512 | 6,533 | 6,468 | 6,267 | 6,563 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 1,033 | 1,016 | 944 | 890 | 859 |
Retained Earnings | 1,782 | 2,170 | 1,746 | 1,303 | 1,249 |
Other Equity | -272 | -343 | -363 | -308 | -343 |
Treasury Stock | 1,806 | 1,738 | 1,247 | 1,072 | 1,072 |
Total Shareholder's Equity | 739 | 1,107 | 1,082 | 815 | 695 |
Total Liabilities & Shareholder's Equity | 8,251 | 7,640 | 7,550 | 7,082 | 7,258 |
Total Common Equity | 739 | 1,107 | 1,082 | 815 | 695 |
Shares Outstanding | 148.40 | 150.90 | 162.90 | 164.50 | 163.50 |
Book Value Per Share | 4.98 | 7.34 | 6.64 | 4.95 | 4.25 |
Fiscal Year End for The Chemours Company falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 1,353 | 1,807 | 1,447 | 945 |
Receivables | NA | 792 | 610 | 846 | 890 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 1,391 | 1,352 | 1,314 | 1,446 |
Other Current Assets | NA | 61 | 66 | 76 | 93 |
Total Current Assets | NA | 3,597 | 3,835 | 3,683 | 3,374 |
Net Property & Equipment | NA | 3,209 | 3,216 | 3,119 | 3,190 |
Investments & Advances | NA | 165 | 158 | 192 | 189 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 105 | 105 | 107 | 110 |
Deposits & Other Assets | NA | 650 | 677 | 589 | 553 |
Total Assets | NA | 7,978 | 8,251 | 7,948 | 7,660 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 963 | 1,159 | 901 | 1,009 |
Current Portion Long-Term Debt | NA | 41 | 51 | 23 | 25 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 1,019 | 1,058 | 1,039 | 930 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 208 | 218 | 232 | 226 |
Total Current Liabilities | NA | 2,231 | 2,486 | 2,195 | 2,190 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 44 | 44 | 54 | 58 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 3,968 | 3,987 | 3,944 | 3,604 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 789 | 791 | 802 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 7,224 | 7,512 | 7,191 | 6,850 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 2 | 2 | 2 | 2 |
Capital Surplus | NA | 1,033 | 1,033 | 1,030 | 1,014 |
Retained Earnings | NA | 1,797 | 1,782 | 1,845 | 1,864 |
Other Equity | NA | -272 | -272 | -313 | -280 |
Treasury Stock | NA | 1,806 | 1,806 | 1,807 | 1,790 |
Total Shareholder's Equity | NA | 754 | 739 | 757 | 810 |
Total Liabilities & Shareholder's Equity | NA | 7,978 | 8,251 | 7,948 | 7,660 |
Total Common Equity | 0 | 754 | 739 | 757 | 810 |
Shares Outstanding | 148.90 | 148.90 | 148.40 | 148.40 | 148.00 |
Book Value Per Share | 0.00 | 5.06 | 4.98 | 5.10 | 5.47 |